1. Home
  2. SPCB vs APLT Comparison

SPCB vs APLT Comparison

Compare SPCB & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SuperCom Ltd. (Israel)

SPCB

SuperCom Ltd. (Israel)

HOLD

Current Price

$9.25

Market Cap

38.7M

Sector

Technology

ML Signal

HOLD

Logo Applied Therapeutics Inc.

APLT

Applied Therapeutics Inc.

HOLD

Current Price

$0.26

Market Cap

38.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPCB
APLT
Founded
1988
2016
Country
Israel
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.7M
38.1M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
SPCB
APLT
Price
$9.25
$0.26
Analyst Decision
Strong Buy
Buy
Analyst Count
1
5
Target Price
$18.00
$4.13
AVG Volume (30 Days)
104.4K
25.4M
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.84
N/A
Revenue
$26,739,000.00
$1,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$29.31
$5,935.35
P/E Ratio
$11.03
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.08
$0.22
52 Week High
$18.95
$2.44

Technical Indicators

Market Signals
Indicator
SPCB
APLT
Relative Strength Index (RSI) 45.62 28.38
Support Level $7.98 $0.24
Resistance Level $9.49 $0.27
Average True Range (ATR) 0.80 0.09
MACD 0.01 -0.03
Stochastic Oscillator 46.95 4.80

Price Performance

Historical Comparison
SPCB
APLT

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: